[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565511":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":39,"centralContacts":43,"locations":53,"responsibleParty":68,"collaborators":47,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":47,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":47,"enrollmentInfo":79,"targetDuration":47,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":47,"overallStatus":56,"whyStopped":47,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"JW Pharmaceutical","INDUSTRY",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"JW0104+C2402","EXPERIMENTAL","JW0104+C2402, 8 weeks, QD (Quaque Die)",[13],"Drug: JW0104+C2402",{"label":15,"type":16,"description":17,"interventionNames":18},"JW0104+C2403","ACTIVE_COMPARATOR","JW0104+C2403, 8 weeks, QD",[19],"Drug: JW0104+C2403",{"label":21,"type":16,"description":22,"interventionNames":23},"C2402","C2402, 8 weeks, QD",[24],"Drug: C2402",[26,32,36],{"type":27,"name":9,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","For 8 weeks(PO (Per Oral), QD)",[9],[31],"NA (Not Applicable)",{"type":27,"name":15,"description":33,"armGroupLabels":34,"otherNames":35},"For 8 weeks(PO, QD)",[15],[31],{"type":27,"name":21,"description":33,"armGroupLabels":37,"otherNames":38},[21],[31],[40],{"name":41,"affiliation":5,"role":42},"Minjung Kim","STUDY_CHAIR",[44,49],{"name":41,"role":45,"phone":46,"phoneExt":47,"email":48},"CONTACT","+82-2-840-6861",null,"kmj@jwhealthcare.com",{"name":50,"role":45,"phone":51,"phoneExt":47,"email":52},"Dongryung Lee","+82-2-840-6982","dongryung.lee@jwhealthcare.com",[54],{"facility":55,"status":56,"city":57,"state":47,"zip":58,"country":59,"countryCode":47,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"Gangdong Sacred Heart Hospital","RECRUITING","Seoul","05355","South Korea",{"type":61,"coordinates":62},"Point",[63,64],126.9784,37.566,{"lat":64,"lon":63},[67],{"name":41,"role":45,"phone":46,"phoneExt":47,"email":48},{"type":69,"investigatorFullName":47,"investigatorTitle":47,"investigatorAffiliation":47,"oldNameTitle":47,"oldOrganization":47},"SPONSOR","100565511","phase-3-evaluate-the-efficacy-and-safety-of-co-administration-of-jw0104c2402-in-patients-with-hypertension-and-dyslipidemia-100565511",false,"NCT06643130","Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia","A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia","Inclusion Criteria:\n\n* Patients with hypertension and dyslipidemia\n\nExclusion Criteria:\n\n* The subject not meet the specified msBP and LDL-C level","ALL","19 Years",{"count":80,"type":81},162,"ESTIMATED","INTERVENTIONAL",[84],"PHASE3","A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia",[87,88],"Hypertension","Dyslipidemia","2025-09-02",{"date":91,"type":92},"2025-09-09","ACTUAL",{"date":94,"type":92},"2024-12-02",{"date":96,"type":81},"2026-04",{"name":5,"class":6},1]